Imatinib 400 mg film-coated tablets

Licence status
Withdrawn: 04/12/2023
Active substances
Imatinib mesilate
Dosage Form
Film-coated tablet
Licence number
PA2059/002/002
Licence holder
Fresenius Kabi Deutschland GmbH

Product documents

Licence information

ATC code
L01XE Protein kinase inhibitors, L01XE01 imatinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).
Marketing availability
Not marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
08/04/2016